Patent details

LUC00154 Product Name: darolutamide éventuellement sous la forme d'un sel ou d'un ester pharmaceutiquement acceptable de celui-ci

Basic Information

Publication number:
LUC00154
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP107819187
Legal Status:
Inactive
Application number:
LUC00154
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/20/1432/001
Marketing Authorization Type:
Marketing Authorization Date:
30/03/2020
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
19/05/2020
First Marketing Authorization date:
30/03/2020
Grant date:
17/02/2021
Activation date:
Publication date:
19/05/2020
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
30/03/2035
SPC Extension Expiration:
30/03/2035
Rejection date:
Withdrawal date:

Owner

From:
19/05/2020
 
 

Name:
Orion Corporation
Address:
Orionintie 1, 02200 Espoo, Finland (FI)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
19/05/2020
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2020/07
Publication date:
12/06/2020
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2021/04
Publication date:
08/03/2021
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
31/10/2030
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
19/05/2020 Outgoing Correspondence 1
19/05/2020 Application Form 4
19/05/2020 General Document 3
19/05/2020 General Document 3
17/02/2021 Certificate 1
17/02/2021 Outgoing Correspondence 1
19/05/2020 Publication 1
17/02/2021 Publication 1
19/05/2020 General Document 29